| Literature DB >> 31807287 |
Xiaojun Guan1, Tao Guo1, Qiaoling Zeng1, Jiaqiu Wang2, Cheng Zhou1, Chunlei Liu3,4, Hongjiang Wei4, Yuyao Zhang4, Min Xuan1, Quanquan Gu1, Xiaojun Xu1, Peiyu Huang1, Jiali Pu2, Baorong Zhang2, Min-Ming Zhang1.
Abstract
BACKGROUND: Different oscillations of brain networks could carry different dimensions of brain integration. We aimed to investigate oscillation-specific nodal alterations in patients with Parkinson's disease (PD) across early stage to middle stage by using graph theory-based analysis.Entities:
Keywords: Akinesia and rigidity; Functional magnetic resonance imaging; Graph theory analysis; Network; Oscillation frequency; Parkinson’s disease
Year: 2019 PMID: 31807287 PMCID: PMC6857322 DOI: 10.1186/s40035-019-0177-5
Source DB: PubMed Journal: Transl Neurodegener ISSN: 2047-9158 Impact factor: 8.014
The distribution of demographic and clinical information
| Item | PD | EPD | MPD | NC | ||||
|---|---|---|---|---|---|---|---|---|
| Number (F/M) | 88 (38/50) | 39 (18/21) | 49 (20/29) | 36 (20/16) | 0.210 | 0.491 | 0.195 | 0.668 |
| Age, mean ± SD | 59.72 ± 8.99 | 56.48 ± 8.15 | 62.30 ± 8.86 | 58.14 ± 8.09 | 0.360 | 1.000 | 0.078 | 0.005 |
| Duration, mean ± SD | 3.73 ± 3.32 | 3.37 ± 3.58 | 4.01 ± 3.11 | – | – | – | – | 0.375 |
| MMSE, mean ± SD | 27.22 ± 2.51 | 28.08 ± 1.87 | 26.53 ± 2.76 | 28.69 ± 1.65 | 0.001ab | 0.096ab | < 0.001ab | 0.004ab |
| Education, mean ± SD | 8.34 ± 4.82 | 10.03 ± 4.09 | 7.00 ± 4.96 | 11.23 ± 3.63 | 0.002a | 0.157a | < 0.001a | 0.005a |
| Hoehn-Yahr stage, mean ± SD | 1.69 ± 0.54 | 1.14 ± 0.23 | 2.13 ± 0.22 | – | – | – | – | < 0.001 |
| UPDRS motor score, mean ± SD | 24.68 ± 13.52 | 14.79 ± 6.09 | 32.55 ± 12.61 | 0.64 ± 1.13 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
| Akinesia/rigidity score, mean ± SD | 15.95 ± 9.54 | 8.85 ± 3.92 | 21.61 ± 8.89 | – | – | – | – | < 0.001 |
| Tremor score, mean ± SD | 4.05 ± 3.95 | 2.54 ± 1.77 | 5.24 ± 4.74 | – | – | – | – | < 0.001 |
| Head motion, mean ± SD | 0.128 ± 0.077 | 0.121 ± 0.077 | 0.134 ± 0.077 | 0.129 ± 0.065 | 0.512a | 0.252a | 0.922a | 0.380a |
aMann-Whitney U test or Kruskal-Wallis test
bNo significance after adjusting education
-: Data not available
PD Parkinson’s disease, EPD Early stage Parkinson’s disease, MPD Middle stage Parkinson’s disease, NC Normal controls
MMSE Mini-Mental State Examination, UPDRS United Parkinson’s disease Rating Scale
Fig. 1The effect of oscillation frequencies on network properties. Paired t-tests were performed to identify the effect of oscillation frequencies. We used a false-positive correction of each node, p = 1/112 (1/N) = 0.009, where N is the number of comparisons, which implies that we expected less than one false positive per analysis on average. All the nodes showing in this figure had significantly differences between frequencies. The red color represented increased values and the blue color represented decreased values. The bigger nodal size indicated the larger absolute t value
Fig. 2Oscillation-specific alterations of nodal degree centrality in parkinsonian status. Red nodes indicated PD patients had higher decree centrality than normal controls while blue nodes indicated PD patients had lower degree centrality than normal controls. The big nodes were significantly different between groups (p < 0.009). For a better visualization and comparison, if one of either side node showing a significant difference (p < 0.009), the contralateral nodes with p < 0.05 were also visualized but in the small size
Oscillation-specific alterations of degree centrality between/among groups
| Node | Slow-5 [mean (SD)] | Slow-4 [mean (SD)] | Slow-3 [mean (SD)] | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD | EPD | MPD | NC | PD | EPD | MPD | NC | PD | EPD | MPD | NC | |
| Put.L | 13.99 (5.80)** | 12.57 (5.82) | 15.13 (5.58)** | 10.36 (6.56) | 11.13 (5.84) | 9.97 (6.07) | 12.06 (5.54) | 9.24 (5.77) | 10.35 (5.99) | 8.25 (5.58) | 12.01 (5.84) | 9.20 (6.00) |
| Put.R | 14.08 (5.85)** | 12.55 (5.54) | 15.30 (5.85)** | 10.45 (6.28) | 11.18 (5.89) | 10.63 (5.77) | 11.61 (6.01) | 8.96 (5.78) | 10.78 (6.21) | 9.04 (5.85) | 12.17 (6.19) | 9.58 (6.21) |
| Pall.L | 13.59 (6.11) | 11.95 (5.71) | 14.89 (6.16)** | 10.61 (5.56) | 13.55 (6.09) | 12.54 (4.87) | 12.55 (5.77) | 11.73 (6.40) | 10.16 (5.72) | 8.19 (5.41) | 11.73 (5.51) | 9.60 (6.32) |
| Pall.R | 14.08 (5.96) | 13.43 (6.08) | 14.59 (5.87) | 11.40 (6.31) | 12.75 (5.44) | 12.54 (4.87) | 12.91 (5.90) | 11.65 (6.77) | 10.14 (5.57) | 8.25 (4.49) | 11.64 (5.67) | 8.85 (5.69) |
| Thal.L | 14.83 (7.44)* | 12.94 (7.44) | 16.33 (7.15)* | 11.05 (7.34) | 14.77 (8.26) | 13.24 (8.08) | 15.98 (8.28) | 11.85 (8.44) | 11.25 (7.79) | 8.86 (7.26) | 13.15 (7.74) | 8.11 (7.11) |
| Thal.R | 15.11 (7.60)** | 13.18 (7.88) | 16.65 (7.08)** | 10.62 (7.30) | 15.54 (8.60) | 14.26 (8.65) | 16.57 (8.52) | 11.59 (7.930 | 11.65 (7.93) | 9.61 (7.77) | 13.28 (7.74) | 8.49 (7.04) |
| Accbns.L | 10.86 (5.75) | 10.06 (5.71) | 11.49 (5.77) | 9.45 (5.71) | 8.75 (5.39)** | 8.62 (5.91) | 8.84 (5.00) | 6.17 (4.17) | 5.65 (4.17) | 4.13 (3.31) | 6.86 (4.42)**## | 3.92 (3.41) |
| Accbns.R | 10.94 (6.03) | 10.70 (6.40) | 11.13 (5.78) | 9.69 (5.49) | 8.58 (5.19) | 8.27 (5.46) | 8.83 (5.00) | 7.56 (5.89) | 5.75 (4.44) | 3.93 (3.69) | 7.20 (4.48)**## | 3.63 (2.94) |
| F3 t.L | 12.43 (6.27) | 13.77 (6.09) | 11.36 (6.26) | 13.63 (7.25) | 10.20 (5.17)** | 9.59 (4.84)** | 10.68 (5.41)* | 13.94 (5.64) | 11.86 (5.58) | 11.73 (5.64) | 11.97 (5.58) | 14.59 (5.95) |
| F3 t.R | 14.17 (5.84) | 14.79 (6.25) | 13.68 (5.52) | 14.52 (6.83) | 13.71 (4.90) | 13.51 (4.65) | 13.88 (5.14) | 14.44 (5.97) | 15.29 (5.48) | 15.53 (5.98) | 15.10 (4.90) | 15.46 (5.65) |
| FMC.L | 10.95 (6.30) | 10.90 (5.89) | 10.99 (6.66) | 10.41 (6.42) | 9.72 (5.46) | 9.81 (5.20) | 9.65 (5.70) | 7.68 (4.56) | 7.97 (5.56)** | 8.26 (5.62) | 7.75 (5.56) | 4.88 (4.25) |
| FMC.R | 10.89 (6.58) | 11.46 (6.07) | 10.43 (6.98) | 11.26 (5.94) | 9.49 (5.64) | 10.57 (5.57) | 8.64 (5.61) | 7.37 (5.54) | 7.18 (5.19)* | 7.97 (5.67) | 6.56 (4.74) | 4.83 (5.11) |
| FOC.L | 19.08 (4.58) | 19.34 (4.28) | 18.87 (4.84) | 17.74 (5.75) | 17.83 (6.10) | 17.92 (5.95) | 17.75 (6.28) | 16.79 (7.05) | 16.24 (6.68) | 16.92 (6.50) | 15.71 (6.83) | 14.71 (5.31) |
| FOC.R | 18.35 (5.24) | 18.34 (5.34) | 18.35 (5.22) | 16.48 (6.15) | 18.36 (5.64)** | 17.50 (5.69) | 19.05 (5.56)** | 14.60 (6.63) | 16.15 (6.35) | 16.27 (6.30) | 16.06 (6.45) | 13.24 (5.97) |
| T2a.L | 11.77 (6.01) | 13.27 (6.31) | 10.57 (5.53) | 12.13 (6.01) | 12.88 (5.07) | 13.71 (4.94) | 12.22 (5.13) | 13.30 (5.24) | 11.46 (5.95) | 13.57 (6.46) | 9.78 (4.97)## | 11.91 (5.68) |
| T2a.R | 12.38 (5.89) | 14.17 (5.47) | 10.95 (5.88) | 12.16 (6.12) | 13.01 (6.14) | 13.24 (6.45) | 12.83 (5.95) | 12.80 (5.62) | 12.42 (5.66) | 12.84 (5.72) | 12.07 (5.66) | 11.97 (6.40) |
| OP.L | 9.71 (5.84)** | 10.43 (5.89) | 9.14 (5.80)** | 13.26 (6.29) | 9.48 (5.25)* | 11.09 (5.15) | 8.20 (5.02)**# | 12.12 (5.12) | 12.58 (5.71) | 14.67 (5.80) | 10.91 (5.11)**# | 15.34 (5.18) |
| OP.R | 9.69 (6.34)* | 11.62 (6.39) | 8.16 (5.93)**# | 12.75 (5.68) | 9.09 (5.28)** | 10.72 (4.98) | 7.80 (5.20)**# | 12.10 (5.13) | 11.55 (5.63) | 14.13 (5.50) | 9.51 (4.89)**## | 13.40 (5.60) |
| OLs.L | 14.95 (5.41) | 15.54 (5.66) | 14.48 (5.21) | 16.16 (5.46) | 17.69 (5.00) | 18.69 (4.60) | 16.89 (5.21) | 19.00 (4.98) | 19.95 (4.64) | 21.77 (4.15) | 18.49 (4.52)**## | 21.58 (4.27) |
| OLs.R | 14.70 (5.68) | 14.98 (6.19) | 14.48 (5.29) | 15.11 (5.76) | 17.49 (4.50) | 17.78 (4.60) | 17.26 (4.45) | 18.09 (5.11) | 19.76 (5.08) | 21.46 (4.20) | 18.40 (5.35)*# | 21.15 (3.87) |
Put putamen, Pall pallidum, Thal thalamus, Accbns accumbens, F3 t inferior frontal gyrus, pars triangularis, FMC frontal medial cortex, FOC frontal orbital cortex, T2a middle temporal gyrus, anterior division, OP occipital pole, OLs lateral occipital cortex, superior division, PD Parkinson’s disease, EPD early stage Parkinson’s disease, MPD middle stage Parkinson’s disease, NC normal controls
*/**: Comparisons between PD group(s) and normal controls with p < 0.05/p < 0.009, respectively
#/##: Comparisons between PD groups with p < 0.05/p < 0.009, respectively
Of note, only when one of either side node showing a significant difference (p < 0.009) did the contralateral node with p < 0.05 was listed by *(**)/#(##)
Fig. 3Oscillation-specific alterations of nodal efficiency in parkinsonian status. Red nodes indicated PD patients had higher nodal efficiency than normal controls while blue nodes indicated PD patients had lower nodal efficiency than normal controls. The big nodes were significantly different between groups (p < 0.009). For a better visualization and comparison, if one of either side node showing a significant difference (p < 0.009), the contralateral nodes with p < 0.05 were also visualized but in the small size
Oscillation-specific alterations of nodal efficiency between/among groups
| Node | Slow-5 [mean (SD)] | Slow-4 [mean (SD)] | Slow-3 [mean (SD)] | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD | EPD | MPD | NC | PD | EPD | MPD | NC | PD | EPD | MPD | NC | |
| Put.L | 0.255 (0.043)** | 0.245 (0.045) | 0.263 (0.040)** | 0.218 (0.062) | 0.235 (0.054) | 0.223 (0.059) | 0.244 (0.048) | 0.216 (0.054) | 0.217 (0.065) | 0.195 (0.071) | 0.235 (0.054) | 0.202 (0.070) |
| Put.R | 0.255 (0.042)** | 0.245 (0.042) | 0.264 (0.040)** | 0.221 (0.059) | 0.235 (0.053) | 0.228 (0.055) | 0.240 (0.050) | 0.214 (0.056) | 0.220 (0.065) | 0.200 (0.072) | 0.237 (0.055) | 0.204 (0.070) |
| Pall.L | 0.251 (0.047) | 0.240 (0.046) | 0.259 (0.046)** | 0.226 (0.052) | 0.252 (0.049) | 0.246 (0.044) | 0.257 (0.052) | 0.231 (0.060) | 0.217 (0.062) | 0.195 (0.067) | 0.234 (0.053) | 0.202 (0.070) |
| Pall.R | 0.254 (0.045) | 0.249 (0.047) | 0.257 (0.044) | 0.229 (0.063) | 0.247 (0.046) | 0.247 (0.037) | 0.247 (0.052) | 0.228 (0.069) | 0.216 (0.060) | 0.196 (0.063) | 0.233 (0.053) | 0.196 (0.072) |
| Bst.L | 0.239 (0.049)* | 0.237 (0.044) | 0.240 (0.052) | 0.215 (0.071) | 0.233 (0.053) | 0.237 (0.047) | 0.229 (0.058) | 0.208 (0.072) | 0.209 (0.061) | 0.211 (0.063) | 0.208 (0.060) | 0.178 (0.073) |
| Bst.R | 0.244 (0.046)** | 0.241 (0.042) | 0.246 (0.050) | 0.209 (0.073) | 0.238 (0.053) | 0.237 (0.046) | 0.238 (0.059) | 0.212 (0.072) | 0.215 (0.061) | 0.214 (0.062) | 0.215 (0.060) | 0.186 (0.076) |
| Accbns.L | 0.231 (0.046) | 0.226 (0.046) | 0.236 (0.046) | 0.215 (0.058) | 0.214 (0.056)** | 0.207 (0.068) | 0.220 (0.044) | 0.183 (0.063) | 0.172 (0.067) | 0.151 (0.064) | 0.189 (0.066)**# | 0.142 (0.064) |
| Accbns.R | 0.230 (0.050) | 0.228 (0.051) | 0.232 (0.049) | 0.217 (0.057) | 0.213 (0.053)* | 0.207 (0.059) | 0.218 (0.047) | 0.192 (0.067) | 0.172 (0.069) | 0.145 (0.069) | 0.194 (0.062)**## | 0.143 (0.060) |
| F3 t.L | 0.244 (0.046) | 0.254 (0.043) | 0.236 (0.048) | 0.248 (0.051) | 0.237 (0.035)** | 0.233 (0.033)** | 0.241 (0.036) | 0.258 (0.031) | 0.243 (0.038) | 0.241 (0.037) | 0.244 (0.038) | 0.257 (0.037) |
| F3 t.R | 0.257 (0.038) | 0.262 (0.038) | 0.253 (0.039) | 0.252 (0.058) | 0.258 (0.034) | 0.256 (0.033) | 0.259 (0.035) | 0.258 (0.040) | 0.264 (0.032) | 0.265 (0.031) | 0.264 (0.032) | 0.261 (0.040) |
| FOC.L | 0.288 (0.026) | 0.291 (0.023) | 0.286 (0.028) | 0.276 (0.038) | 0.282 (0.041) | 0.282 (0.041) | 0.282 (0.040) | 0.271 (0.049) | 0.267 (0.048) | 0.271 (0.044) | 0.263 (0.051) | 0.257 (0.041) |
| FOC.R | 0.282 (0.039) | 0.283 (0.033) | 0.281 (0.044) | 0.268 (0.045) | 0.285 (0.036)** | 0.280 (0.040) | 0.290 (0.033)** | 0.257 (0.051) | 0.268 (0.042) | 0.269 (0.039) | 0.267 (0.045) | 0.246 (0.050) |
| T2p.L | 0.256 (0.035) | 0.262 (0.033) | 0.251 (0.036) | 0.253 (0.035) | 0.268 (0.028) | 0.264 (0.029) | 0.271 (0.028) | 0.271 (0.021) | 0.274 (0.026) | 0.276 (0.027) | 0.272 (0.026) | 0.269 (0.025) |
| T2p.R | 0.259 (0.036) | 0.262 (0.031) | 0.256 (0.039) | 0.252 (0.049) | 0.276 (0.027) | 0.269 (0.028) | 0.281 (0.024)**# | 0.265 (0.023) | 0.282 (0.027) | 0.278 (0.025) | 0.285 (0.028) | 0.269 (0.036) |
| AG.L | 0.244 (0.041) | 0.252 (0.034) | 0.237 (0.045) | 0.232 (0.052) | 0.254 (0.034) | 0.253 (0.026) | 0.254 (0.040) | 0.253 (0.030) | 0.264 (0.029) | 0.264 (0.031) | 0.264 (0.028) | 0.258 (0.034) |
| AG.R | 0.240 (0.045)** | 0.237 (0.037) | 0.242 (0.051) | 0.211 (0.059) | 0.257 (0.027) | 0.248 (0.031) | 0.265 (0.021)**# | 0.243 (0.030) | 0.267 (0.031) | 0.256 (0.034) | 0.276 (0.026) | 0.254 (0.034) |
| OP.L | 0.219 (0.055)** | 0.228 (0.051) | 0.212 (0.057)** | 0.247 (0.045) | 0.226 90.045) | 0.240 (0.037) | 0.215 (0.048)** | 0.245 (0.034) | 0.246 (0.039) | 0.259 (0.036) | 0.236 (0.039)**# | 0.262 (0.032) |
| OP.R | 0.215 (0.065)* | 0.233 (0.060) | 0.201 (0.066)** | 0.243 (0.045) | 0.223 (0.044) | 0.237 (0.037) | 0.212 (0.046)**# | 0.245 (0.035) | 0.240 (0.039) | 0.256 (0.037) | 0.228 (0.037)*## | 0.251 (0.035) |
| OLs.L | 0.261 (0.038) | 0.267 (0.037) | 0.257 (0.038) | 0.266 (0.037) | 0.281 (0.031) | 0.287 (0.028) | 0.277 (0.032) | 0.287 (0.026) | 0.291 (0.026) | 0.300 (0.023) | 0.283 (0.026)*## | 0.297 (0.023) |
| OLs.R | 0.258 (0.046) | 0.261 (0.047) | 0.256 (0.046) | 0.260 (0.038) | 0.282 (0.025) | 0.283 (0.025) | 0.281 (0.025) | 0.281 (0.027) | 0.289 (0.029) | 0.298 (0.023) | 0.283 (0.032)# | 0.295 (0.021) |
Put putamen, Pall pallidum, Bst brain stem, Accbns accumbens, F3 t inferior frontal gyrus, pars triangularis, FOC frontal orbital cortex, T2p middle temporal gyrus, posterior division, AG angular gyrus, OP occipital pole, OLs lateral occipital cortex, superior division, PD Parkinson’s disease, EPD early stage Parkinson’s disease, MPD middle stage Parkinson’s disease, NC normal controls
*/**: Comparisons between PD group(s) and normal controls with p < 0.05/p < 0.009, respectively
#/##: Comparisons between PD groups with p < 0.05/p < 0.009, respectively
Of note, only when one of either side node showing a significant difference (p < 0.009) did the contralateral node with p < 0.05 was listed by *(**)/#(##)
Fig. 4Correlations of occipital degree centrality with clinical symptoms in specific slow-3 oscillation frequency. a-d separately showed clinical correlations of four occipital nodes. Significant correlations between occipital degree centrality and total motor score (UPDRS motor score) were first observed, which was survived after Bonferroni correction. Then, in order to identify which component of motor symptoms contributed dominantly to the alterations of nodal decree centrality, we correlated each motor subscale (akinesia/rigidity and tremor) with occipital degree centrality. The red solid regression line indicated that the correlation was significant. And the blue dot line indicated the 95% prediction interval of the regression line (red solid line)
Fig. 5Correlations of occipital nodal efficiency with clinical symptoms in specific slow-3 oscillation frequency. a-d separately showed clinical correlations of four occipital nodes. Significant correlations between occipital nodal efficiency and total motor score (UPDRS motor score) were first observed, which was survived after Bonferroni correction. Then, in order to identify which component of motor symptoms contributed dominantly to the alterations of nodal efficiency, we correlated each motor subscale (akinesia/rigidity and tremor) with occipital nodal efficiency. The red solid regression line indicated that the correlation was significant. And the blue dot line indicated the 95% prediction interval of the regression line (red solid line)
Fig. 6ROC curves for the discriminations between PD patients and controls and between EPD and MPD according to the logistic regression analyses. a showed the ability of altered nodal properties within specific oscillation frequencies to discriminate PD patients from controls, while (b) showed the ability of altered nodal properties within specific oscillation frequencies to discriminate MPD from EPD patients. The red points were representing the locations of the best discriminative results determined by Youden index